Bay Harbor Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bay Harbor Wealth Management's PFE Position: Q2 2026 in Review
Bay Harbor Wealth Management increased its Pfizer (PFE) stake by 348% in Q2 2026, buying an estimated $52.9K and bringing the position to 2,605 shares worth $62.7K. The position accounts for 0.01% of the portfolio, ranked #137.
Bay Harbor Wealth Management first reported a position in PFE in Q4 2018 and has held it in 18 quarters since. The position peaked at $447K in Q4 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bay Harbor Wealth Management held 2,605 shares of Pfizer worth $62.7K as of Q2 2026.
- Bay Harbor Wealth Management bought 2,024 Pfizer shares in Q2 2026, an estimated $52.9K.
- Pfizer made up 0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #137 holding.
- Bay Harbor Wealth Management first reported a position in Pfizer in Q4 2018 and has held it in 18 quarters since.
- Bay Harbor Wealth Management's Pfizer position peaked at $447K in Q4 2019.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.